Android app on Google Play

Sinovac Biotech Ltd. (SVA) Posts Mixed Q3 Results; Reaffirms Outlook

November 15, 2010 8:02 AM EST Send to a Friend
Get Alerts SVA Hot Sheet
Price: $5.41 -1.46%

Today's EPS Names:
KOSS, GEF, CCUR, More
Trade SVA Now!
Join SI Premium – FREE
Sinovac Biotech Ltd. (NYS: SVA) reports Q3 loss of $0.01, versus the analyst estimate of $0.02. Revenue for the quarter came in at $9.55 million, versus the consensus estimate of $9.53 million.

Reaffirms FY10 outlook.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Add Your Comment